WallStSmart

Arcosa Inc (ACA)vsEMCOR Group Inc (EME)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

EMCOR Group Inc generates 489% more annual revenue ($16.99B vs $2.88B). EME leads profitability with a 7.5% profit margin vs 7.2%. EME appears more attractively valued with a PEG of 1.08. EME earns a higher WallStSmart Score of 64/100 (C+).

ACA

Buy

64

out of 100

Grade: C+

Growth: 5.3Profit: 5.5Value: 10.0Quality: 7.0
Piotroski: 3/9Altman Z: 1.73

EME

Buy

64

out of 100

Grade: C+

Growth: 8.7Profit: 7.0Value: 10.0Quality: 6.3
Piotroski: 5/9Altman Z: 4.41
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

ACAUndervalued (+35.6%)

Margin of Safety

+35.6%

Fair Value

$198.43

Current Price

$106.72

$91.71 discount

UndervaluedFair: $198.43Overvalued
EMEUndervalued (+38.8%)

Margin of Safety

+38.8%

Fair Value

$1320.70

Current Price

$764.76

$555.94 discount

UndervaluedFair: $1320.70Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

ACA1 strengths · Avg: 8.0/10
Price/BookValuation
2.0x8/10

Reasonable price relative to book value

EME4 strengths · Avg: 9.5/10
Return on EquityProfitability
38.5%10/10

Every $100 of equity generates 39 in profit

EPS GrowthGrowth
53.0%10/10

Earnings expanding 53.0% YoY

Altman Z-ScoreHealth
4.4110/10

Safe zone — low bankruptcy risk

Revenue GrowthGrowth
19.7%8/10

19.7% revenue growth

Areas to Watch

ACA4 concerns · Avg: 3.5/10
EPS GrowthGrowth
3.4%4/10

3.4% earnings growth

Altman Z-ScoreHealth
1.734/10

Distress zone — elevated risk

Profit MarginProfitability
7.2%3/10

7.2% margin — thin

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

EME3 concerns · Avg: 3.7/10
P/E RatioValuation
27.1x4/10

Moderate valuation

Price/BookValuation
9.3x4/10

Trading at 9.3x book value

Profit MarginProfitability
7.5%3/10

7.5% margin — thin

Comparative Analysis Report

WallStSmart Research

Bull Case : ACA

The strongest argument for ACA centers on Price/Book. PEG of 1.38 suggests the stock is reasonably priced for its growth.

Bull Case : EME

The strongest argument for EME centers on Return on Equity, EPS Growth, Altman Z-Score. Revenue growth of 19.7% demonstrates continued momentum. PEG of 1.08 suggests the stock is reasonably priced for its growth.

Bear Case : ACA

The primary concerns for ACA are EPS Growth, Altman Z-Score, Profit Margin.

Bear Case : EME

The primary concerns for EME are P/E Ratio, Price/Book, Profit Margin.

Key Dynamics to Monitor

ACA profiles as a value stock while EME is a growth play — different risk/reward profiles.

EME carries more volatility with a beta of 1.14 — expect wider price swings.

EME is growing revenue faster at 19.7% — sustainability is the question.

EME generates stronger free cash flow (492M), providing more financial flexibility.

Bottom Line

ACA scores higher overall (64/100 vs 64/100). EME offers better value entry with a 38.8% margin of safety. Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Arcosa Inc

INDUSTRIALS · ENGINEERING & CONSTRUCTION · USA

Arcosa, Inc. provides infrastructure related products and solutions for the construction, energy and transportation markets in North America. The company is headquartered in Dallas, Texas.

Visit Website →

EMCOR Group Inc

INDUSTRIALS · ENGINEERING & CONSTRUCTION · USA

EMCOR Group, Inc. provides electrical and mechanical installation and construction services in the United States. The company is headquartered in Norwalk, Connecticut.

Want to dig deeper into these stocks?